Furthermore, after IRs, infections were the next leading reason behind discontinuation. RA despite treatment with methotrexate with least an added disease-modifying anti-rheumatic medication. Patients had been treated with 3 mg/kg infliximab at weeks 0, 2, and 6 and every eight weeks then. At weeks 0, 6, 26, 50, and 74, Continue Reading